Brief: Microba Life Sciences Says FY25 Revenue A$15.67M
22/07/2025 02:15
July 22 (Reuters) - Microba Life Sciences Ltd MAP.AX: Q4 FY25 QUARTERLY ACTIVITIES REPORT & APPENDIX 4C FY25 REVENUE A$15.67M Further company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement